Javier Salmerón

5.5k total citations · 1 hit paper
80 papers, 3.2k citations indexed

About

Javier Salmerón is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, Javier Salmerón has authored 80 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Hepatology, 43 papers in Epidemiology and 11 papers in Rheumatology. Recurrent topics in Javier Salmerón's work include Hepatitis C virus research (46 papers), Liver Disease Diagnosis and Treatment (27 papers) and Hepatitis B Virus Studies (26 papers). Javier Salmerón is often cited by papers focused on Hepatitis C virus research (46 papers), Liver Disease Diagnosis and Treatment (27 papers) and Hepatitis B Virus Studies (26 papers). Javier Salmerón collaborates with scholars based in Spain, United States and Italy. Javier Salmerón's co-authors include Raúl J. Andrade, Manuel Romero‐Gómez, A. Ruiz‐Extremera, M. Diago, A. Gila, Conrado Fernández‐Rodríguez, M. Isabel Lucena, J.M. Navarro, Ramón Planas and Josefa León and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Javier Salmerón

79 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients

2005 556 citations Manuel Romero‐Gómez, Raúl J. Andrade et al. Gastroenterology profile →

Peers

Javier Salmerón

HEPAT

EPIDE

PHARM

ONCOL

Isabelle Colle Belgium

Yves Horsmans Belgium

Yvon Calmus France

Jaw‐Ching Wu Taiwan

Keisuke Hino Japan

Thomas S. Chen United States

M. Angélico Italy

Hirotoshi Ebinuma Japan

Jean‐Michel Fabre France

Mark Avigan United States

Isabelle Colle Belgium

Javier Salmerón

3.1k ×1.7

HEPAT

2.4k ×1.3

EPIDE

224 ×0.3

PHARM

330 ×0.8

ONCOL

794 ×2.0

Citations per year, relative to Javier Salmerón Javier Salmerón (= 1×) peers Isabelle Colle

Countries citing papers authored by Javier Salmerón

Since Specialization

Citations

This map shows the geographic impact of Javier Salmerón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Salmerón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Salmerón more than expected).

Fields of papers citing papers by Javier Salmerón

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Salmerón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Salmerón. The network helps show where Javier Salmerón may publish in the future.

Co-authorship network of co-authors of Javier Salmerón

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Salmerón. A scholar is included among the top collaborators of Javier Salmerón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Salmerón. Javier Salmerón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Arana, Carlos, Luis Ángel García-Escudero, Javier Salmerón, et al.. (2021). In Patients With Obesity, the Number of Adipose Tissue Mast Cells Is Significantly Lower in Subjects With Type 2 Diabetes. Frontiers in Immunology. 12. 11 indexed citations

Cuypers, Lize, Ana Belén Pérez, Natalia Chueca, et al.. (2018). Relapse or reinfection after failing hepatitis C direct acting antiviral treatment: Unravelled by phylogenetic analysis. PLoS ONE. 13(7). e0201268–e0201268. 11 indexed citations

León, Josefa, et al.. (2018). Cytometric analysis of adipose tissue reveals increments of adipocyte progenitor cells after weight loss induced by bariatric surgery. Scientific Reports. 8(1). 15203–15203. 27 indexed citations

Ruiz‐Extremera, A., Mário Florido, Paloma Muñoz de Rueda, et al.. (2017). Influence of HLA class I, HLA class II and KIRs on vertical transmission and chronicity of hepatitis C virus in children. PLoS ONE. 12(2). e0172527–e0172527. 8 indexed citations

Martín‐Guerrero, Sandra M., José Antonio Muñoz‐Gámez, Maria‐Carmen Carrasco, et al.. (2017). Poly(ADP-ribose)polymerases inhibitors prevent early mitochondrial fragmentation and hepatocyte cell death induced by H2O2. PLoS ONE. 12(10). e0187130–e0187130. 13 indexed citations

Rodríguez, Manuel, J.M. Pascasio, Enrique Fraga, et al.. (2017). Tenofovir vs lamivudine plus adefovir in chronic hepatitis B: TENOSIMP-B study. World Journal of Gastroenterology. 23(41). 7459–7469. 6 indexed citations

Muñoz‐Gámez, José Antonio, Javier Salmerón, & A. Ruiz‐Extremera. (2016). Hepatitis C durante la gestación, transmisión vertical y nuevas posibilidades de tratamiento. Medicina Clínica. 147(11). 499–505. 4 indexed citations

Muñoz‐de‐Rueda, Paloma, A. Gila, R. Quiles, et al.. (2012). Importance of IL-10 and IL-6 during chronic hepatitis c genotype-1 treatment and their relation with IL28B. Cytokine. 61(2). 595–601. 16 indexed citations

López-Viota, M., et al.. (2012). Functionalized magnetic nanoparticles as vehicles for the delivery of the antitumor drug gemcitabine to tumor cells. Physicochemical in vitro evaluation. Materials Science and Engineering C. 33(3). 1183–1192. 33 indexed citations

10.

Ruiz‐Extremera, A., R. Quiles, Ana Belén Barragán Martín, et al.. (2011). Plasma Ribavirin Trough Concentrations During Treatment of Chronic Hepatitis C in Genotype-1 Patients. Journal of Clinical Gastroenterology. 46(4). 328–333. 5 indexed citations

11.

Ruiz‐Extremera, A., José Antonio Muñoz‐Gámez, Paloma Muñoz de Rueda, et al.. (2011). Genetic variation in interleukin 28B with respect to vertical transmission of hepatitis C virus and spontaneous clearance in HCV-infected children. Hepatology. 53(6). 1830–1838. 95 indexed citations

12.

Muñoz‐Gámez, José Antonio, R. Quiles, A. Ruiz‐Extremera, et al.. (2010). Inhibition of poly (ADP-ribose) polymerase-1 enhances doxorubicin activity against liver cancer cells. Cancer Letters. 301(1). 47–56. 23 indexed citations

13.

García-García, José Ángel, Manuel Romero‐Gómez, J.A. Girón González, et al.. (2006). Incidence of and Factors Associated with Hepatocellular Carcinoma among Hepatitis C Virus and Human Immunodeficiency Virus Coinfected Patients with Decompensated Cirrhosis. AIDS Research and Human Retroviruses. 22(12). 1236–1241. 15 indexed citations

14.

Salmerón, Javier, M. Diago, Raúl J. Andrade, et al.. (2006). Induction doses of interferon‐α‐2a in combination with ribavirin and/or amantadine for the treatment of chronic hepatitis C in non‐responders to interferon monotherapy: a randomized trial. Journal of Viral Hepatitis. 14(2). 89–95. 4 indexed citations

15.

Andrade, Raúl J., M. Isabel Lucena, M. Carmen Fernández, et al.. (2005). Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period. Gastroenterology. 129(2). 512–521. 66 indexed citations

16.

Pineda, Juan A., Manuel Romero‐Gómez, J.A. Girón González, et al.. (2005). HIV coinfection shortens the survival of patients with hepatitis C virus‐related decompensated cirrhosis†. Hepatology. 41(4). 779–789. 212 indexed citations

17.

Andrade, Raúl J., M. Isabel Lucena, Miren García‐Cortés, et al.. (2004). HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease. Hepatology. 39(6). 1603–1612. 108 indexed citations

18.

Zubiaur, Mercedes, O. Fernández, Enza Ferrero, et al.. (2002). CD38 Is Associated with Lipid Rafts and upon Receptor Stimulation Leads to Akt/Protein Kinase B and Erk Activation in the Absence of the CD3-ζ Immune Receptor Tyrosine-based Activation Motifs. Journal of Biological Chemistry. 277(1). 13–22. 92 indexed citations

19.

Navarro, J., J. Maldonado, Eduardo Narbona, et al.. (1999). Influence of dietary nucleotides on plasma immunoglobulin levels and lymphocyte subsets of preterm infants. BioFactors. 10(1). 67–76. 35 indexed citations

20.

Salmerón, Javier, et al.. (1996). [Hepatitis C virus genotypes].. PubMed. 19(5). 274–80. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact